JPH06237734A - Food composition for hypofunctional disease - Google Patents
Food composition for hypofunctional diseaseInfo
- Publication number
- JPH06237734A JPH06237734A JP3290073A JP29007391A JPH06237734A JP H06237734 A JPH06237734 A JP H06237734A JP 3290073 A JP3290073 A JP 3290073A JP 29007391 A JP29007391 A JP 29007391A JP H06237734 A JPH06237734 A JP H06237734A
- Authority
- JP
- Japan
- Prior art keywords
- food
- weight
- food material
- oil
- functional
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明はエイコサペンタエン酸1
5±10重量%、ドコサヘキサエン酸15±10重量
%、αーリノレン酸20±15重量%を少なくとも1種
以上含む油脂成分40±35重量%と、タンパク質30
±20重量%、所望によりレシチン10±5重量%を含
有する組成物を特徴とする機能改善性食品材料、並びに
該材料を含有する半固形状あるいは固形状を有する機能
性食品に係る。FIELD OF THE INVENTION The present invention relates to eicosapentaenoic acid 1
5 ± 10% by weight, 15 ± 10% by weight of docosahexaenoic acid, 20 ± 15% by weight of α-linolenic acid, 40 ± 35% by weight of fats and oils, and protein 30
The present invention relates to a function-improving food material characterized by a composition containing ± 20% by weight, and optionally 10 ± 5% by weight of lecithin, and a semi-solid or solid functional food containing the material.
【0002】[0002]
【従来技術】近年、平均寿命の伸び傾向や過労、社会環
境の変化等に伴うストレスを原因とする、アルツハイマ
ー、痴呆、記憶障害、失語、失行、精神疾患など現代病
が注目されつつある。このうち脳機能障害については現
在のところ有効に治療できる薬剤は皆無に等しく、治療
方法の確立が望まれている。2. Description of the Related Art In recent years, modern diseases such as Alzheimer's disease, dementia, memory impairment, aphasia, apraxia, and mental illness, which are caused by stress associated with the tendency of life expectancy extension, overwork, changes in social environment, etc., are drawing attention. Of these, there are almost no drugs that can effectively treat cerebral dysfunction at present, and establishment of a treatment method is desired.
【0003】エイコサぺンタエン酸(EPA)やドコサ
ヘキサエン酸(DHA)は血栓溶解作用を有する魚油と
して知られ、脳機能改善効果、記憶増強効果は知られて
いるが、酸化されやすく、不快臭も強く、食品材料とし
ては不向きであった(特開平2−49723号、特開平
3ー58926等)。また健康食品として、ゼラチン軟
カプセルで包装した製剤が動脈硬化症の改善性食品とし
て市販されているが、経口後の胸焼け、げっぷ、悪臭な
ど副作用が指摘されている。また、油脂のサイクロデキ
ストリンのような包接組成物であっても、製造後数ケ月
で変色、変敗しやすい欠陥があり、変敗物質の毒性の問
題も指摘されている。従って、食品材料として、経時的
変化を受けにくく、安全性や薬理活性が高く、かつ魚油
臭がない製品はこれまで発見されていないのが現状であ
る。Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are known as fish oils having a thrombolytic effect and are known to have a brain function improving effect and a memory enhancing effect, but are easily oxidized and have a strong unpleasant odor. However, it was not suitable as a food material (JP-A-2-49723, JP-A-3-58926, etc.). As a health food, a formulation packaged in soft gelatin capsules is marketed as an arteriosclerosis-improving food, but side effects such as heartburn, belching and malodor after oral administration have been pointed out. Further, even an inclusion composition such as cyclodextrin of fats and oils has a defect that it is easily discolored and decomposed within a few months after production, and the problem of toxicity of the deteriorated substance has been pointed out. Therefore, at present, as a food material, a product that is not easily changed with time, has high safety and pharmacological activity, and has no fish oil odor has not been found until now.
【0004】[0004]
【発明が解決しようとする課題】本発明はこのような観
点のもとで、簡便な使用形態を有し、保存安定性に優
れ、組織機能改善効果ことに脳組織機能改善効果を有す
る食品材料用組成物並びに、該食品材料により調製され
た機能性食品を提供するものである。Based on this point of view, the present invention is a food material which has a simple use form, is excellent in storage stability, and has a tissue tissue improving effect and a brain tissue function improving effect. And a functional food prepared from the food material.
【0005】[0005]
【課題を解決するための手段】本発明者らは鋭意研究を
重ねた結果、エイコサペンタエン酸15±10重量%、
ドコサヘキサエン酸15±10重量%、αーリノレン酸
20±15重量%を少なくとも1種以上含む油脂成分4
0±25重量%と、タンパク質30±20重量%、所望
によりレシチン10±5重量%を含有する組成物が保存
性、安定性、加工性に富み、食品材料として有用性が高
い事。更にまた、これを材料とした半固形、固形製品が
嗜好性も良好であり、機能改善効果にあっても原材料
(本発明食品材料)と比較して活性が低下しない事を見
出し本発明を完成するに至った。Means for Solving the Problems As a result of intensive studies, the present inventors have found that eicosapentaenoic acid 15 ± 10% by weight,
Oil and fat component 4 containing at least one docosahexaenoic acid 15 ± 10% by weight and α-linolenic acid 20 ± 15% by weight
A composition containing 0 ± 25% by weight, 30 ± 20% by weight of protein and, if desired, 10 ± 5% by weight of lecithin has excellent storage stability, stability and processability, and is highly useful as a food material. Furthermore, they have found that semi-solid and solid products made from this material have good palatability, and their activity is not reduced compared to the raw material (the food material of the present invention) even if they have a function improving effect, thus completing the present invention. Came to do.
【0006】本発明組成物の調製にあたっては、通常油
脂成分に同分量のタンパクを混合させる事により調製さ
れるが、エイコサペンタエン酸、ドコサヘキサエン酸、
αーリノレン酸の精製品は高価であり、通常はエイコサ
ペンタエン酸、ドコサヘキサエン酸を通常10%以上含
有するイワシ油、サバ油、ニシン油、魚卵肝油、海草油
などを用いる事ができる。また、αーリノレン酸にあっ
てはゴマ油シソ油等を使用する事ができる。In the preparation of the composition of the present invention, it is usually prepared by mixing an equal amount of protein with an oil and fat component. Eicosapentaenoic acid, docosahexaenoic acid,
The refined product of α-linolenic acid is expensive, and sardine oil, mackerel oil, herring oil, roe liver oil, seaweed oil, etc., which usually contain 10% or more of eicosapentaenoic acid and docosahexaenoic acid can be used. For α-linolenic acid, sesame oil and perilla oil can be used.
【0007】なお、エイコサペンタエン酸、ドコサヘキ
サエン酸の高純度精製品を使用する場合は、油脂の増量
剤としてαーリノレン酸系ゴマ油、シソ油で配合量を調
節する事ができる。When a highly purified product of eicosapentaenoic acid or docosahexaenoic acid is used, the blending amount can be adjusted with α-linolenic acid-based sesame oil and perilla oil as a fat and oil extender.
【0008】レシチン成分としては、大豆レシチン、卵
黄レシチンが使用され、タンパク質成分としては、一般
公知の動物、植物性タンパク質などが利用されるが、油
脂に対する抗酸化作用の強い、ラクトアルブミン、カゼ
イン、大豆タンパク質、卵白アルブミンの使用が好まし
い。As the lecithin component, soybean lecithin and egg yolk lecithin are used, and as the protein component, generally known animals, vegetable proteins and the like are used, but lactalbumin, casein, which has a strong antioxidant effect on oils and fats, The use of soy protein, ovalbumin is preferred.
【0009】本発明組成物の調製により得られた、食品
材料はそのままでも各種の機能改善効果を有するが、保
存安定性、加熱安定性、加工性に富んでおり、機能改善
効果を有するマーガリン、バター、チーズ、クリーム、
フレッシュ、マヨネーズ、ミルク、コーヒー、ココア、
プロテイン飲料、スープ、ドレッシング等の液体あるい
は半固形状を有する機能性食品として、また、ブロッ
ク、クッキー、ウエハース、キャラメル、チョコレー
ト、粉乳、ココアの素、プリンの素等の固形状を有する
機能性食品として提供される。Although the food material obtained by the preparation of the composition of the present invention has various function improving effects as it is, margarine having excellent function improving effect is excellent in storage stability, heat stability and processability. Butter, cheese, cream,
Fresh, mayonnaise, milk, coffee, cocoa,
Liquid or semi-solid functional foods such as protein drinks, soups, dressings, etc., and functional foods with solid forms such as blocks, cookies, wafers, caramel, chocolate, milk powder, cocoa powder, and pudding powder. Provided as.
【0010】[0010]
【使用量】機能性食品としての効果を期待する本発明食
品材料の投与量は成人1日あたり、EPA、DHAとし
て10g以下好ましくは0.1〜2.0g程度が使用さ
れる。[Amount to be used] The dose of the food material of the present invention, which is expected to be effective as a functional food, is 10 g or less, preferably 0.1 to 2.0 g or less as EPA and DHA per day for an adult.
【0011】[0011]
【発明の効果】本発明は各種の機能障害の改善剤、こと
にアルツハイマー、痴呆、記憶障害、失語、失行、精神
疾患並びに脳梗塞、脳動脈硬化症及びこれに伴う症状の
改善用食品材料を提供すると共に、該食品材料により調
製される固形、半固形性機能性食品を提供する。INDUSTRIAL APPLICABILITY The present invention is an agent for improving various functional disorders, particularly Alzheimer's disease, dementia, memory disorder, aphasia, apraxia, mental illness and cerebral infarction, cerebral arteriosclerosis and food materials for improving symptoms associated therewith. And a solid or semi-solid functional food prepared by the food material.
【0012】本発明食品材料はDHA、EPAの安全
性、加工性やその活性を高める共に安全性も高く連続投
与が可能である。また本発明食品材料の加工により得ら
れる機能性食品類は脳機能後退性疾患ことに老人病、精
神病の進行阻止及び脳梗塞、脳動脈硬化症の如き閉塞性
疾患の諸症状の改善に有効で嗜好性に富んだ機能性食品
である。以下には実施例(製造例、薬効薬理試験例)を
あげ本発明を更に詳細に説明する。The food material of the present invention enhances the safety and processability of DHA and EPA and the activity thereof, and is highly safe and can be continuously administered. Further, the functional foods obtained by processing the food material of the present invention are effective in improving various symptoms of obstructive diseases such as cerebral infarction and cerebral infarction and cerebral infarction, cerebral infarction and cerebral arteriosclerosis. It is a functional food with rich palatability. Hereinafter, the present invention will be described in more detail with reference to Examples (Production Examples, Pharmacological and Pharmacological Test Examples).
【0013】実施例1(食品材料) 精製魚油(EPA:18wt%DHA:12wt%を含む)36重
量部、エゴマ油(αーリノレン酸:56wt%を含む)18重
量部、レシチン6重量部の混合物を50゜Cに加温し、そ
こに大豆蛋白40重量部を添加して攪拌乳化した。これを
室温まで冷却し、EPA、DHA、αーリノレン酸含有
の半固形食品材料を得た。Example 1 (Food material) A mixture of 36 parts by weight of refined fish oil (containing 18% by weight of DPA: 12% by weight), 18 parts by weight of perilla oil (containing 56% by weight of α-linolenic acid), and 6 parts by weight of lecithin. Was heated to 50 ° C, 40 parts by weight of soybean protein was added thereto, and the mixture was emulsified with stirring. This was cooled to room temperature to obtain a semi-solid food material containing EPA, DHA and α-linolenic acid.
【0014】実施例2(食品材料) 水50重量部に第1表に示す材料100重量部を添加して70
゜Cに加温し、攪拌乳化した。これを真空乾燥器にて乾
燥した後、粉砕してEPA、DHA、αーリノレン酸含
有の粉末状食品材料を得た。Example 2 (food material) 100 parts by weight of the material shown in Table 1 was added to 50 parts by weight of water to give 70 parts.
The mixture was heated to ° C and emulsified with stirring. This was dried in a vacuum dryer and then pulverized to obtain a powdery food material containing EPA, DHA and α-linolenic acid.
【0015】 〔第1表〕 精製魚油 23% エゴマ油 11% 精製魚油はEPA18wt%、DHA レシチン 4% 12wt%を含む。エゴマ油はαー ラクトアルブミン 24% リノレン酸56wt%を含む。 フレーバー 2% デキストリン 36% 合 計 100%[Table 1] Refined fish oil 23% Perilla oil 11% Refined fish oil contains EPA 18 wt% and DHA lecithin 4% 12 wt%. Perilla oil contains α-lactalbumin 24% linolenic acid 56 wt%. Flavor 2% Dextrin 36% Total 100%
【0016】実施例3(機能性食品〜プリンの素1) 以下第2表に示す材料を混合しEPA、DHA、αーリ
ノレン酸含有プリンの素を得た。Example 3 (Functional Food-Purine Element 1) The materials shown in Table 2 below were mixed to obtain an EPA, DHA, and α-linolenic acid-containing purine element.
【0017】 〔第2表〕 実施例2に示す粉末状の食品材料 10 33% 砂 糖 9 30% 全脂粉乳 7 24% 脱脂粉乳 3 10% カラギナン 0.7 2.4% エッグパウダー 0.1 0.3% 食 塩 0.1 0.3% 香料 微量 微量 合 計 30 100%[Table 2] Powdered food material shown in Example 2 10 33% Sand sugar 9 30% Whole milk powder 7 24% Skim milk powder 3 10% Carrageenan 0.7 2.4% Egg powder 0.1 0.3% Food salt 0.1 0.3% Fragrance trace amount Total 30 100%
【0018】実施例4(プリンの調製1) 水70重量部に実施例で得たプリンの素30重量部を添加
し、混合しながら沸騰させた。これを容器に入れ、冷却
してEPA、DHA、αーリノレン酸含有プリンを得
た。Example 4 (Preparation 1 of Pudding) 30 parts by weight of the purine material obtained in Example was added to 70 parts by weight of water, and boiled while mixing. This was placed in a container and cooled to obtain EPA, DHA, and α-linolenic acid-containing purine.
【0019】実施例5(機能性食品〜プリンの素2) 以下第3表に示す材料を混合しEPA、DHA、αーリ
ノレン酸含有プリンの素を得た。Example 5 (Functional Food-Purine Element 2) The materials shown in Table 3 below were mixed to obtain an EPA, DHA, and α-linolenic acid-containing purine element.
【0020】 〔第3表〕 実施例2に示す粉末状の食品材料 10 50% 砂 糖 9 45% カラギナン 0.8 4% エッグパウダー 0.1 0.5% 食 塩 0.1 0.5% 香 料 微量 微量 20 100%[Table 3] Powdered food material shown in Example 2 10 50% Sand sugar 9 45% Carrageenan 0.8 4% Egg powder 0.1 0.5% Food salt 0.1 0.5% Fragrance Traces 20 Traces 100%
【0021】実施例6(プリンの調製2) 牛乳80重量部に実施例5で得たプリンの素20重量部を添
加し、混合しながら沸騰させた。これを容器を入れ、冷
却してEPA、DHA、αーリノレン酸含有プリンを得
た。Example 6 (Preparation 2 of Pudding) 20 parts by weight of the purine obtained in Example 5 was added to 80 parts by weight of milk and boiled while mixing. This was put in a container and cooled to obtain EPA, DHA, and α-linolenic acid-containing purine.
【0022】 実施例7(機能性食品〜クリームサンドウエハース) 実施例1に示した半固形食品材料100重量部に砂糖100重
量部、香料2重量部を添加して50゜Cで攪拌して均質化
し、EPA、DHA、αーリノレン酸含有クリームとし
た、これをウエハースにはさみ、室温まで冷却し、クリ
ームサンドウエハースとした。Example 7 (Functional Food to Cream Sand Wafer) To 100 parts by weight of the semi-solid food material shown in Example 1, 100 parts by weight of sugar and 2 parts by weight of flavor are added, and the mixture is stirred at 50 ° C. to homogeneity. The resulting cream was EPA, DHA, and α-linolenic acid-containing cream, which was sandwiched between wafers and cooled to room temperature to obtain cream sand wafers.
【0023】実施例8(機能性食品〜マヨネーズ) 以下第4表に示す材料を混合し均質化して、EPA、D
HA、αーリノレン酸含有マヨネーズを得た。Example 8 (Functional Food to Mayonnaise) The materials shown in Table 4 below were mixed and homogenized to obtain EPA and D.
HA and α-linolenic acid-containing mayonnaise were obtained.
【0024】 〔第4表〕 実施例1に示した半固形食品材料 76% 卵 黄 12% 食 酢 10% 食 塩 1% からし 0.5% 砂 糖 2% 調味料 0.5% 合 計 100%[Table 4] Semi-solid food materials shown in Example 1 76% egg yolk 12% food vinegar 10% food salt 1% mustard 0.5% sand sugar 2% seasoning 0.5% total 100%
【0025】実施例9(機能性食品〜マーガリン1) 以下第5表に示す材料を混合し均質化して、EPA、D
HA、αーリノレン酸含有マーガリンを得た。Example 9 (Functional Food to Margarine 1) The materials shown in Table 5 below were mixed and homogenized to obtain EPA and D.
HA and α-linolenic acid-containing margarine were obtained.
【0026】 [0026]
【0027】実施例10(機能性食品〜マーガリン2) 以下第6表に示す材料のうち実施例1に示した半固形食
品材料、硬化油、ビタミンE、モノグリセリド、フレー
バーを50゜Cで混合した。これに脱脂粉乳、食塩を水に
溶解させた50゜Cに加温した液を少しずつ加えながら攪
拌した。これを急冷して混和し、均質化して、EPA、
DHA、αーリノレン酸含有マーガリンを得た。Example 10 (Functional Food to Margarine 2) Of the materials shown in Table 6 below, the semi-solid food material, hydrogenated oil, vitamin E, monoglyceride and flavor shown in Example 1 were mixed at 50 ° C. . A mixture of skim milk powder and salt dissolved in water and heated at 50 ° C was added little by little to this, and the mixture was stirred. This is rapidly cooled, mixed, homogenized, EPA,
A margarine containing DHA and α-linolenic acid was obtained.
【0028】 [0028]
【0029】実施例11(機能性食品〜ブロック) 第7表に示す材料を混合したものを形に入れ、90゜Cに
10分間加熱した後、室温まで冷却してEPA、DHA、
αーリノレン酸含有ブロックを得た。Example 11 (Functional food to block) A mixture of the materials shown in Table 7 was put into a mold and the mixture was heated to 90 ° C.
After heating for 10 minutes, cool down to room temperature, then EPA, DHA,
A block containing α-linolenic acid was obtained.
【0030】 [0030]
【0031】安定性試験1(保存安定性) 本発明食品材料及び調製された機能性食品につき6ケ月
間にわたる保存安定性について試験した所、以下表8〜
9に示すように、安定性が極めて高い事が判明した。Stability Test 1 (Storage Stability) The food material of the present invention and the prepared functional food were tested for storage stability for 6 months.
As shown in 9, it was found that the stability was extremely high.
【0032】 〔第8表〕 油分のPOV、保存状態:窒素封入アルミ袋、室温 0ケ月 2ケ月 4ケ月 6ケ月 実施例1 半固形 0.42 0.96 2.05 2.51 実施例2 粉 末 0.51 1.55 1.60 1.95 実施例3 プリンの素 0.76 1.20 1.44 1.38 実施例5 プリンの素 0.59 1.47 1.60 2.06 実施例7 ウエハース 0.91 2.02 3.58 5.21 実施例8 マヨネーズ 0.58 3.81 3.49 4.83 実施例9 マヨネーズ 0.47 2.77 3.50 4.25 実施例11 クッキー 2.28 4.21 5.09 7.18 比較例1 実施例1のレシチン 未添加 0.73 13.8 25 67 比較例2 実施例1の大豆蛋白 未添加 0.56 7.55 18.1 45 比較例3 実施例2のレシチン 未添加 1.83 9.05 34 60 比較例4 実施例2のラクトア ルブミン未添加 1.20 5.32 27 51 比較例5 精製魚油とエゴマ油 (2:1)の混合物 0.81 29 76 163 比較例6 比較例5の窒素未 封入品0.89 145. 377. 681. [Table 8] POV of oil content, storage condition: nitrogen-filled aluminum bag, room temperature 0 month 2 months 4 months 6 months Example 1 Semi-solid 0.42 0.96 2.05 2.51 Example 2 Powder 0.51 1.55 1.60 1.95 Example 3 Purine Element 0.76 1.20 1.44 1.38 Example 5 Purine Element 0.59 1.47 1.60 2.06 Example 7 Wafer 0.91 2.02 3.58 5.21 Example 8 Mayonnaise 0.58 3.81 3.49 4.83 Example 9 Mayonnaise 0.47 2.77 3.50 4.25 Example 11 Cookie 2.28 4.21 5.09 7.18 Comparison Example 1 Lecithin-free 0.73 13.8 25 67 of Example 1 Comparative Example 2 Soy protein-free 0.56 7.55 18.1 45 of Example 1 Comparative Example 3 Lecithin-free 1.83 9.05 34 60 of Example 2 Comparative Example 4 Lactor of Example 2 Lubumin-free 1.20 5.32 27 51 Comparative Example 5 A mixture of refined fish oil and perilla oil (2: 1) 0.81 29 76 163 Comparative Example 6 Non- encapsulated product of Comparative Example 5 0.89 145. 377. 681.
【0033】 〔第9表〕 油分のPOV、保存状態:窒素封入アルミ袋、室温 0ケ月 2ケ月 4ケ月 6ケ月 実施例4 プリン 0.73 1.50 2.88 5.01 実施例5 プリン 0.59 1.01 2.94 4.38 実施例10 マーガリン 0.60 1.93 2.58 5.13 [Table 9] POV of oil content, storage condition: nitrogen-filled aluminum bag, room temperature 0 months 2 months 4 months 6 months Example 4 pudding 0.73 1.50 2.88 5.01 Example 5 pudding 0.59 1.01 2.94 4.38 Example 10 margarine 0.60 1.93 2.58 5.13
【0034】薬効薬理試験 1)マウス健忘症に対する効果 本食品材料のEPA.DHA活性向上効果を一酸化炭素
ガス負荷により惹起される記憶障害モデルを用いて検討
した。Pharmacological and Pharmacological Test 1) Effect on Amnestic Mice in Mouse EPA. The effect of improving DHA activity was examined by using a memory impairment model induced by carbon monoxide gas loading.
【0035】(A)試験方法 a)記銘獲得試行 ddY系マウス(6〜8週齢)一群10匹以上を使用し、
明暗箱の明室部分に入れて、暗室へ移動するまでの平均
時間を測定し(以下A.T.)、暗室に移動した直後に
床のグリッドを介して、2.5mAのフットショックを動
物が明室に移動するまで与え続けた。(A) Test method a) Trial to obtain inscriptions A group of 10 or more ddY mice (6-8 weeks old) was used.
Put it in the light room of the light and dark box, measure the average time to move to the dark room (hereinafter referred to as AT), and immediately after moving to the dark room, apply a 2.5 mA foot shock to the animal through the floor grid. Kept giving until he moved to the bright room.
【0036】b)再試試行 記銘獲得試行の24時間後に動物を再び明暗箱の明室部分
に入れ、暗室に移動する時間を測定した。(以下R.
T.)B) Retrial Trial Twenty-four hours after the trial of retrieving the memory, the animal was placed again in the light room of the light / dark box, and the time for moving to the dark room was measured. (Hereinafter R.
T. )
【0037】c)記銘獲得試行の直後に動物をデシケー
ターに移し、一酸化炭素ガスを1分間あたり15リットル
の割りで注入した。動物をデシケータより出し、直ちに
人工呼吸を施し、呼吸が回復した所でホームケージに移
した。C) Immediately after the inscription trial, the animal was transferred to a desiccator and carbon monoxide gas was injected at a rate of 15 liters per minute. The animals were taken out of the desiccator, immediately given artificial respiration, and transferred to their home cages when breathing was restored.
【0038】d)被検薬物の投与 被検薬物は実施例1の本発明食品材料1g製造例11
のブロック5g、精製魚油360.mgとエゴマ油179.mg混
合油を使用した。製造例1の本発明食品材料、製造例11
のブロックは塊状に砕きそのまま餌として、混合油は餌
に吸収させ、1日あたりEPA64.8mg、DHA43.2mg、
αーリノレン酸100.mgの理論的摂取量を投与した。D) Administration of test drug The test drug is 1 g of the food material of the present invention of Example 1 Production Example 11
5 g of the above block, 360.mg of purified fish oil and 179.mg of perilla oil were mixed. Inventive food material of Production Example 1, Production Example 11
Block is crushed into lumps as it is, and the mixed oil is absorbed by the food, and EPA64.8mg, DHA43.2mg,
A theoretical intake of 100 mg of α-linolenic acid was administered.
【0039】e)統計処理 R.T.が360秒を越えたものは、R.T.を360秒とし
て、群毎に平均値±標準誤差を算出した。(360秒を越
えたものは、記憶を保持しているものと認定した)E) Statistical processing T. For more than 360 seconds, R. T. Was set to 360 seconds, and the average value ± standard error was calculated for each group. (Anything over 360 seconds was identified as having memory)
【0040】(B)結 果 結果は以下表10に示した。記憶を保持能力について、混
合油も活性が認められるが、単独と比較して本発明食品
材料の方が活性が高く、製品加工しても活性が維持して
いる事が判明した。(B) Results The results are shown in Table 10 below. Regarding the ability to retain memory, the mixed oil also shows activity, but it was found that the food material of the present invention had higher activity than that of the oil alone, and that the activity was maintained even after product processing.
【0041】 〔表10〕 本発明食品材料等の一酸化炭素吸入による記憶障害に対する防御作用 動物数 A.T. R.T. 試験群(foot shock+hypoxia) 製造例1の本発明食品材料 15 38.5±30 284.40±23.1 製造例11のブロック 15 44.2±20 270.70±18.2 混合油 15 51.5±50 205.20±25.7 対照群 foot shock+hypoxia. 15 52.9±8.30 188.30±17.6 foot shock+no-hypoxia 14 68.4±11.1 360 noーfoot shock+hypoxia 13 44.5±9.10 50.60±19.7 [Table 10] Number of animals having protective action against memory impairment due to inhalation of carbon monoxide in food materials of the present invention A. T. R. T. Test group (foot shock + hypoxia) Inventive food material of Production Example 15 38.5 ± 30 284.40 ± 23.1 Block of Production Example 11 15 44.2 ± 20 270.70 ± 18.2 Mixed oil 15 51.5 ± 50 205.20 ± 25.7 Control group foot shock + hypoxia .15 52.9 ± 8.30 188.30 ± 17.6 foot shock + no-hypoxia 14 68.4 ± 11.1 360 no ー foot shock + hypoxia 13 44.5 ± 9.10 50.60 ± 19.7
【0042】使用例(アンケート調査結果) 実施例6におけるプリン形状の機能性食品を成人10名
に1日3回食後2日間食してもらい、味覚試験並びにそ
の思考力の改善効果(記憶力、注意力、寝付具合、睡眠
時間、目覚状態)について聞き取り調査を行った。結果
は、味覚については全員が魚臭を感知せず、良好と答え
た。思考力の改善効果については寝付具合、睡眠時間は
通常通りであると答えた者が多数を占め、記憶力、注意
力、目覚状態については、半数が改善性を訴えた。Example of Use (Results of Questionnaire Survey) 10 adults of the pudding-shaped functional food in Example 6 were eaten 3 times a day for 2 days after eating, and the effect of improving the taste test and its thinking ability (memory, attention) , Sleep condition, sleep time, and wakefulness). Regarding the taste, no one sensed the fishy odor, and answered that the taste was good. The majority of the respondents answered that they were able to improve their thinking ability in terms of bedding and sleep time as usual, and half of them reported improvement in memory, attention, and awake state.
【0043】 アンケート調査項目、回答結果(10名) 1) 味 覚 調 査 良い 普通 悪い a)味はどうですか。 5 5 0 b)匂はどうですか。 3 7 0 c)おいしいと思いますか。 6 3 1Questionnaire survey items and response results (10 persons) 1) Taste investigation Good Normal Poor a) How about the taste? 5 50 b) How about the smell? 370 c) Do you think it is delicious? 6 3 1
【0044】 2)機能性食品作用調査 思う わからない 思わない d)記憶力が良くなったと 3 7 0 思いますか。 e)注意力が良くなったと 思いますか。 5 5 0 f)寝付具合は良くなったと 思いますか。 1 8 1 g)目覚具合は良くなったと 思いますか。 6 3 1 h)夢をよく見るようになっ たと思いますか。 1 8 12) Investigation of functional food effects I don't know Don't think d) 370 Do you think your memory has improved? e) Do you think your attention has improved? 5 50 f) Do you think that your sleeping condition has improved? 1 8 1 g) Do you think your awakening has improved? 6 3 1 h) Do you think you have come to dream more often? 1 8 1
【0045】 3)その他 思う 思わない i)魚油を原料としている事が 0 10 わかると思いますか。 j)しばらくしてからまた 9 1 食べたいと思いますか。3) Others I do not think i) Do you think that you can understand that it is made from fish oil? j) Do you want to eat 91 again after a while?
─────────────────────────────────────────────────────
─────────────────────────────────────────────────── ───
【手続補正書】[Procedure amendment]
【提出日】平成3年11月19日[Submission date] November 19, 1991
【手続補正1】[Procedure Amendment 1]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0023[Name of item to be corrected] 0023
【補正方法】変更[Correction method] Change
【補正内容】[Correction content]
【0023】実施例8(機能性食品〜ドレッシング) 以下、第4表に示す材料を混合し均質化して、EPA、
DHA、αーリノレン酸含有ドレッシングを得た。Example 8 (Functional food to dressing) The materials shown in Table 4 were mixed and homogenized to prepare EPA,
A dressing containing DHA and α-linolenic acid was obtained.
【手続補正2】[Procedure Amendment 2]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0024[Name of item to be corrected] 0024
【補正方法】変更[Correction method] Change
【補正内容】[Correction content]
【0024】 〔第4表〕 実施例1に示した半固形食品材料 60% 果実酢 30% 玉ねぎ汁 5% にんにく汁 3% 塩 1% 砂糖 1% こしょう 0.5% 調味料 0.5% 合 計 100%[Table 4] Semi-solid food material shown in Example 1 60% Fruit vinegar 30% Onion juice 5% Garlic juice 3% Salt 1% Sugar 1% Pepper 0.5% Seasoning 0.5% combined 100% in total
【手続補正3】[Procedure 3]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0028[Correction target item name] 0028
【補正方法】変更[Correction method] Change
【補正内容】[Correction content]
【0028】 〔第6表〕 実施例1に示した半固形食品材料 27% 硬化油 60% ビタミンE 0.04% 乳化剤 1.2% フレーバー 0.04% 水 8.72% 脱脂粉乳 1% 食 塩 2% 合 計 100%[Table 6] Semi-solid food material shown in Example 1 27% Hardened oil 60% Vitamin E 0.04% Emulsifier 1.2% Flavor 0.04% Water 8.72% Nonfat dry milk 1% Food Salt 2% Total 100%
───────────────────────────────────────────────────── フロントページの続き (72)発明者 近 藤 保 昭 名古屋市東区東外堀町35番地 株式会社三 和化学研究所内 (72)発明者 倉 知 忠 史 名古屋市東区東外堀町35番地 株式会社三 和化学研究所内 (72)発明者 二 宮 直 久 名古屋市東区東外堀町35番地 株式会社三 和化学研究所内 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Yasuaki Kondo, 35 Higashi Sotobori-cho, Higashi-ku, Nagoya City Sanwa Chemical Research Institute Co., Ltd. (72) Inventor Tadashi Kurachi 35 Higashi-Tobori-cho, Higashi-ku, Nagoya City Co., Ltd. Inside Sanwa Chemical Research Institute (72) Inventor Naohisa Ninomiya 35 Higashi Sotoboricho, Higashi-ku, Nagoya City Inside Sanwa Chemical Research Institute Co., Ltd.
Claims (4)
ドコサヘキサエン酸15±10重量%、αーリノレン酸
20±15重量%を少なくとも1種以上含む油脂成分4
0±35重量%と、タンパク質30±20重量%、所望
によりレシチン10±5重量%を含有する組成物を主成
分とする機能後退性疾患用食品材料。1. Eicosapentaenoic acid 15 ± 10% by weight,
Oil and fat component 4 containing at least one docosahexaenoic acid 15 ± 10% by weight and α-linolenic acid 20 ± 15% by weight
A food material for functional regression disease, which is mainly composed of a composition containing 0 ± 35% by weight, 30 ± 20% by weight of protein, and optionally 10 ± 5% by weight of lecithin.
ン、大豆タンパク質、卵白アルブミンから選択され、機
能後退性疾患が脳機能後退性疾患である事を特徴とする
請求項1記載の食品材料。2. The food material according to claim 1, wherein the protein is selected from lactalbumin, casein, soybean protein, and ovalbumin, and the functional recession disease is a brain function recession disease.
徴とするマーガリン、バター、チーズ、クリーム、フレ
ッシュ、マヨネーズ、ミルク、コーヒー、ココア、プロ
テイン飲料、スープ、ドレッシング形態を有する液体あ
るいは半固形状を有する機能性食品。3. A liquid or a half having the form of margarine, butter, cheese, cream, fresh, mayonnaise, milk, coffee, cocoa, protein drink, soup, dressing, characterized in that it contains the food material of claim 1. A functional food having a solid state.
徴とするブロック、クッキー、ウエハース、キャラメ
ル、チョコレート、粉乳、ココアの素あるいはココア、
プリンの素あるいはプリン形態を有する固形状を有する
機能性食品。4. A block, cookie, wafer, caramel, chocolate, milk powder, cocoa element or cocoa, which contains the food material according to claim 1.
A functional food having a solid form having a pudding base or pudding form.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3290073A JPH06237734A (en) | 1991-11-06 | 1991-11-06 | Food composition for hypofunctional disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3290073A JPH06237734A (en) | 1991-11-06 | 1991-11-06 | Food composition for hypofunctional disease |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH06237734A true JPH06237734A (en) | 1994-08-30 |
Family
ID=17751444
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3290073A Pending JPH06237734A (en) | 1991-11-06 | 1991-11-06 | Food composition for hypofunctional disease |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH06237734A (en) |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000316525A (en) * | 1999-05-10 | 2000-11-21 | Bizan Yakuhin Kk | Yolk oil-based health food |
WO2000044360A3 (en) * | 1999-01-27 | 2000-11-30 | Laxdale Ltd | Drugs for treatment of psychiatric and brain disorders |
JP2000516261A (en) * | 1997-05-06 | 2000-12-05 | アンスティチュ ドゥ ルシェルシュ ビオロジク ソシエテ アノニム | Novel use in the treatment and / or diet of animal phospholipids |
JP2001031566A (en) * | 1999-07-19 | 2001-02-06 | Taiyo Kagaku Co Ltd | Inhibitory composition for problematic behavior of pet |
WO2003097033A3 (en) * | 2002-05-22 | 2004-03-11 | Synergia Holding | Novel neutracetical and pharmaceutical compositions and their uses |
WO2005046668A1 (en) * | 2003-11-14 | 2005-05-26 | Mochida Pharmaceutical Co., Ltd. | Preventive/therapeutic agent for speech disorder |
WO2007064010A1 (en) * | 2005-12-02 | 2007-06-07 | Mochida Pharmaceutical Co., Ltd. | Preventive/therapeutic agent for alzheimer's dementia |
JPWO2005061684A1 (en) * | 2003-12-22 | 2007-12-13 | 湧永製薬株式会社 | Oil composition |
JP2008174512A (en) * | 2007-01-22 | 2008-07-31 | Kracie Seiyaku Kk | Composition for ameliorating exhausted feeling at time of rising |
WO2009002165A1 (en) * | 2007-06-26 | 2008-12-31 | N.V. Nutricia | Lipid composition for improving brain function |
US7799365B2 (en) | 2001-04-06 | 2010-09-21 | Burnbrae Farms Limited | Liquid egg composition including fish oil with omega-3 fatty acid |
CN102511664A (en) * | 2012-01-16 | 2012-06-27 | 天津农学院 | Fish oil feed additive and production method thereof |
US8282965B2 (en) | 2007-12-20 | 2012-10-09 | N.V. Nutricia | Liquid nucleotides/nucleosides-containing product |
US8361989B2 (en) | 2007-06-26 | 2013-01-29 | N. V. Nutricia | Supporting activities of daily living |
US8445458B2 (en) | 2007-06-27 | 2013-05-21 | N. V. Nutricia | Food composition for prodromal dementia patients |
CN104770715A (en) * | 2015-03-02 | 2015-07-15 | 陈学沛 | Brain-tonifying and intelligence-developing health product |
CN106912942A (en) * | 2017-03-16 | 2017-07-04 | 哈尔滨紫苏生命科技健康产业有限公司 | Lutein purple perilla method for producing soft capsule |
JP2018030795A (en) * | 2016-08-23 | 2018-03-01 | 株式会社Hbcフナト | Brain function-improving composition |
ES2663392R1 (en) * | 2016-05-17 | 2018-05-10 | Universidad De La Laguna | Nutritional supplement for the protection of neurons against the risk of Alzheimer's and Parkinson's in women combining isoflavones and docosahexaenoic acid. |
WO2021183749A1 (en) * | 2020-03-12 | 2021-09-16 | Sancilio Fred D | A composition comprising docosahexaenoic acid and egg yolk suitable for sickle cell disease treatment |
-
1991
- 1991-11-06 JP JP3290073A patent/JPH06237734A/en active Pending
Cited By (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000516261A (en) * | 1997-05-06 | 2000-12-05 | アンスティチュ ドゥ ルシェルシュ ビオロジク ソシエテ アノニム | Novel use in the treatment and / or diet of animal phospholipids |
WO2000044360A3 (en) * | 1999-01-27 | 2000-11-30 | Laxdale Ltd | Drugs for treatment of psychiatric and brain disorders |
JP2000316525A (en) * | 1999-05-10 | 2000-11-21 | Bizan Yakuhin Kk | Yolk oil-based health food |
JP2001031566A (en) * | 1999-07-19 | 2001-02-06 | Taiyo Kagaku Co Ltd | Inhibitory composition for problematic behavior of pet |
JP4669095B2 (en) * | 1999-07-19 | 2011-04-13 | 太陽化学株式会社 | Composition for suppressing behavioral problems in pets |
US7799365B2 (en) | 2001-04-06 | 2010-09-21 | Burnbrae Farms Limited | Liquid egg composition including fish oil with omega-3 fatty acid |
US7740885B2 (en) | 2002-05-22 | 2010-06-22 | Fresaxal Holding, Inc. | Nutraceutical and pharmaceutical compositions and their uses |
WO2003097033A3 (en) * | 2002-05-22 | 2004-03-11 | Synergia Holding | Novel neutracetical and pharmaceutical compositions and their uses |
WO2005046668A1 (en) * | 2003-11-14 | 2005-05-26 | Mochida Pharmaceutical Co., Ltd. | Preventive/therapeutic agent for speech disorder |
JPWO2005061684A1 (en) * | 2003-12-22 | 2007-12-13 | 湧永製薬株式会社 | Oil composition |
WO2007064010A1 (en) * | 2005-12-02 | 2007-06-07 | Mochida Pharmaceutical Co., Ltd. | Preventive/therapeutic agent for alzheimer's dementia |
JP5043677B2 (en) * | 2005-12-02 | 2012-10-10 | 持田製薬株式会社 | Alzheimer's disease prevention and treatment |
JPWO2007064010A1 (en) * | 2005-12-02 | 2009-05-07 | 持田製薬株式会社 | Alzheimer's disease prevention and treatment |
US8461141B2 (en) | 2005-12-02 | 2013-06-11 | Mochida Pharmaceutical Co., Ltd. | Preventive or therapeutic drug for Alzheimer-type dementia |
JP2008174512A (en) * | 2007-01-22 | 2008-07-31 | Kracie Seiyaku Kk | Composition for ameliorating exhausted feeling at time of rising |
US8283335B2 (en) | 2007-06-26 | 2012-10-09 | N.V. Nutricia | Lipid composition for improving brain function |
WO2009002165A1 (en) * | 2007-06-26 | 2008-12-31 | N.V. Nutricia | Lipid composition for improving brain function |
US8791089B2 (en) | 2007-06-26 | 2014-07-29 | N.V. Nutricia | Supporting activities of daily living |
CN101742926A (en) * | 2007-06-26 | 2010-06-16 | N.V.努特里奇亚 | Lipid composition for improving brain function |
US8361989B2 (en) | 2007-06-26 | 2013-01-29 | N. V. Nutricia | Supporting activities of daily living |
US8759319B2 (en) | 2007-06-26 | 2014-06-24 | N.V. Nutricia | Lipid composition for improving brain function |
US8445458B2 (en) | 2007-06-27 | 2013-05-21 | N. V. Nutricia | Food composition for prodromal dementia patients |
US8604000B2 (en) | 2007-12-20 | 2013-12-10 | N.V. Nutricia | Palatable nutritional composition comprising a nucleotide and/or a nucleoside and a taste masking agent |
US8282965B2 (en) | 2007-12-20 | 2012-10-09 | N.V. Nutricia | Liquid nucleotides/nucleosides-containing product |
US9132196B2 (en) | 2007-12-20 | 2015-09-15 | N. V. Nutricia | Palatable nutritional composition comprising a nucleotide and/or a nucleoside and a taste masking agent |
US9687555B2 (en) | 2007-12-20 | 2017-06-27 | N.V. Nutricia | Palatable nutritional composition comprising a nucleotide and/or a nucleoside and a taste masking agent |
CN102511664A (en) * | 2012-01-16 | 2012-06-27 | 天津农学院 | Fish oil feed additive and production method thereof |
CN104770715A (en) * | 2015-03-02 | 2015-07-15 | 陈学沛 | Brain-tonifying and intelligence-developing health product |
ES2663392R1 (en) * | 2016-05-17 | 2018-05-10 | Universidad De La Laguna | Nutritional supplement for the protection of neurons against the risk of Alzheimer's and Parkinson's in women combining isoflavones and docosahexaenoic acid. |
JP2018030795A (en) * | 2016-08-23 | 2018-03-01 | 株式会社Hbcフナト | Brain function-improving composition |
CN106912942A (en) * | 2017-03-16 | 2017-07-04 | 哈尔滨紫苏生命科技健康产业有限公司 | Lutein purple perilla method for producing soft capsule |
WO2021183749A1 (en) * | 2020-03-12 | 2021-09-16 | Sancilio Fred D | A composition comprising docosahexaenoic acid and egg yolk suitable for sickle cell disease treatment |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH06237734A (en) | Food composition for hypofunctional disease | |
KR100951756B1 (en) | Oil composition | |
DE60115660T2 (en) | OIL / GREASE COMPOSITION | |
JP4381037B2 (en) | Oil composition | |
JP4031219B2 (en) | Oil composition | |
CN101340819A (en) | Dietary supplements and prepared foods containing triglyceride-recrystallized non-esterified phytosterols | |
JP4738714B2 (en) | EPA high-concentration soymilk and production method thereof | |
AU2002245977B2 (en) | Liquid egg product | |
JP6609555B2 (en) | Brain function improving agent and preventive or therapeutic agent for cognitive impairment | |
JP3941073B2 (en) | Oil and fat composition and food containing the same | |
RU2347385C2 (en) | Method of taste magnifier usage containing high eicosanoic acid with long chain and/or compound ether | |
DE10109798A1 (en) | Food additives for treatment or prevention of symptoms of diabetes, osteoarthritis, osteoporosis, asthma, mental decline and age related eye disease | |
JP2022116116A (en) | Food-and-drink composition | |
TW201112969A (en) | Eating assistance fat composition for people who have difficulty swallowing and/or chewing and food thereof | |
JPH11246399A (en) | Lipid metabolism improving composition | |
JP2005097161A (en) | Anti-fatigue composition and food containing the same | |
TW201440807A (en) | Oral composition | |
JP2013209493A (en) | Powdery oil and fat, method for producing the same, powdery oil and fat-containing food, powdery oil and fat-containing oral medicinal product, and method for producing the powdery oil and fat-containing food | |
JP2004261005A (en) | Ubidecarenone preparation | |
JP2015057979A (en) | Fat having improved oxidation stability and method for producing the same | |
JP2005047851A (en) | Ubidecarenone-containing composition | |
JPH03220123A (en) | Appetite supressant and food containing the same suppressant | |
JP4143251B2 (en) | Fortified food | |
JP4971575B2 (en) | Composition for improving bioavailability of polyunsaturated fatty acid | |
JP2005000126A (en) | Method for producing fermented soybean paste |